Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF
Read time: 1 mins
Last updated:5th Mar 2013
The purpose of this study is to test the efficacy of a single injection of Canakinumab on AF recurrences within 6 months after electrical cardioversion in patients with persistent AF.
|Study start date||2013-03-05|